KIDRON MIRIAM (Chief Scientific Officer) received a stock award from ORAMED PHARMACEUTICALS INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 3/18/2026ACC: 0001213900-26-031015
DirectorOfficer· Chief Scientific Officer
Since Feb 2019
+119.56K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
119.56K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+119.56K
Price / share
—
Trade value
—
% of position
8.3%
3/17/2026
1.45M→1.57M
Total
Net shares
+119.56K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/17/2026 | A · Award | +119.56K | — | — | 8.3% | 1.45M | 1.57M |
| Total | +119.56K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported